Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Journal of the American College of Cardiology
|
January 3, 2024
Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting
Anne Bellemain-Appaix, Gilles Montalescot
International Journal of Cardiology
|
April 4, 2015
Impressive progression of coronary artery disease assessed by serial multimodality imaging in a 40 year-old patient with Behçet's disease
Sofiene Rekik, François Bernasconi, Armand Eker, et al.
Circulation
|
November 19, 2014
Pretreatment with P2Y12 inhibitors in non-ST-Segment-elevation acute coronary syndrome: an outdated and harmful strategy
Jean-Philippe Collet, Johanne Silvain, Anne Bellemain-Appaix, et al.
Circulation. Cardiovascular Interventions
|
February 18, 2011
Optimal use of thienopyridines in non-ST-elevation acute coronary syndrome following CURRENT-OASIS 7
Johanne Silvain, Anne Bellemain-Appaix, Olivier Barthélémy, et al.
The American Journal of Cardiology
|
August 21, 2010
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates
Farzin Beygui, Johanne Silvain, Ana Pena, et al.
Journal of the American College of Cardiology
|
August 31, 2010
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis
Anne Bellemain-Appaix, David Brieger, Farzin Beygui, et al.
Circulation. Cardiovascular Interventions
|
October 6, 2011
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients
Jean-Sébastien Hulot, Jean-Philippe Collet, Guillaume Cayla, et al.
Journal of the American College of Cardiology
|
July 13, 2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis
Jean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 8, 2024
Impact of coronary sinus reducer on absolute coronary blood flow and microvascular resistance
Clément Servoz, Stefan Verheye, Francesco Giannini, et al.
Case Reports in Cardiology
|
September 13, 2021
Anomalous Left Coronary Artery Connected to the Pulmonary Artery in a 15-Year-Old Girl: Case Report and Discussion on Secondary Prevention of Sudden Death
Jérémy Laïk, Virginie Fouilloux, Philippe Aldebert, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Journal of the American College of Cardiology
|
January 3, 2024
Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting
Anne Bellemain-Appaix, Gilles Montalescot
International Journal of Cardiology
|
April 4, 2015
Impressive progression of coronary artery disease assessed by serial multimodality imaging in a 40 year-old patient with Behçet's disease
Sofiene Rekik, François Bernasconi, Armand Eker, et al.
Circulation
|
November 19, 2014
Pretreatment with P2Y12 inhibitors in non-ST-Segment-elevation acute coronary syndrome: an outdated and harmful strategy
Jean-Philippe Collet, Johanne Silvain, Anne Bellemain-Appaix, et al.
Circulation. Cardiovascular Interventions
|
February 18, 2011
Optimal use of thienopyridines in non-ST-elevation acute coronary syndrome following CURRENT-OASIS 7
Johanne Silvain, Anne Bellemain-Appaix, Olivier Barthélémy, et al.
The American Journal of Cardiology
|
August 21, 2010
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates
Farzin Beygui, Johanne Silvain, Ana Pena, et al.
Journal of the American College of Cardiology
|
August 31, 2010
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis
Anne Bellemain-Appaix, David Brieger, Farzin Beygui, et al.
Circulation. Cardiovascular Interventions
|
October 6, 2011
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients
Jean-Sébastien Hulot, Jean-Philippe Collet, Guillaume Cayla, et al.
Journal of the American College of Cardiology
|
July 13, 2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis
Jean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 8, 2024
Impact of coronary sinus reducer on absolute coronary blood flow and microvascular resistance
Clément Servoz, Stefan Verheye, Francesco Giannini, et al.
Case Reports in Cardiology
|
September 13, 2021
Anomalous Left Coronary Artery Connected to the Pulmonary Artery in a 15-Year-Old Girl: Case Report and Discussion on Secondary Prevention of Sudden Death
Jérémy Laïk, Virginie Fouilloux, Philippe Aldebert, et al.
Page
of 5